Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|April 28, 2022
NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cellsJean Carlos Lipreri da Silva, Maria Fernanda Lopes Carvalho, Livia Bassani Lins de Miranda, et al.
Annals of Hematology|December 11, 2024
All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutationsSilvia Elena Sánchez-Mendoza, Virginia Mara de Deus-Wagatsuma, Mariane Cristina do Nascimento, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 1, 2021
Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemiaJean Carlos Lipreri da Silva, Juan Luiz Coelho-Silva, Keli Lima, et al.
Blood Cells, Molecules & Diseases|August 1, 2015
Differential profile of PIP4K2A expression in hematological malignanciesKeli Lima, Daniela Maria Ribeiro, Paula de Melo Campos, et al.
Hematology, Transfusion and Cell Therapy|February 7, 2024
Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agentsMaria Fernanda Lopes Carvalho, Bruna Oliveira de Almeida, Maura Lima Pereira Bueno, et al.
Toxicology and Applied Pharmacology|December 6, 2025
In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemiaGiorgio Antoniolli, Gilberto Carlos Franchi Junior, Keli Lima, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 3, 2021
Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cellsCatarina Sofia Mateus Reis-Silva, Paola Cristina Branco, Keli Lima, et al.
Clinics (Sao Paulo, Brazil)|July 7, 2024
Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cellsMaria Fernanda Lopes Carvalho, Carolina Santana Calicchio, Bruna Oliveira de Almeida, et al.
Oncology Letters|June 30, 2021
Targeting glioma cells by antineoplastic activity of reversineCamila Hirakata, Keli Lima, Bruna Oliveira De Almeida, et al.
Cell Death Discovery|April 5, 2025
Enhancing venetoclax efficacy in leukemia through association with HDAC inhibitorsJorge Antonio Elias Godoy Carlos, Mauricio Temotheo Tavares, Keli Lima, et al.
Pageof 5